登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：603605 证券简称：珀莱雅 公告编号：2025-057 债券代码：113634 债券简称：珀莱转债 珀莱雅化妆品股份有限公司 关于召开2025年半年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 董事、总经理、财务负责人（代行）：侯亚孟先生 独立董事：马冬明先生、葛伟军先生 重要内容提示： 会议召开时间：2025年9月29日(星期一) 14:00-15:00 会议召开地点：上海证券交易所上证路演中心（以下简称"上证路演中心"）（网址： https://roadshow.sseinfo.com/） 会议召开方式：图文展示+网络文字互动问答 问题征集方式：投资者可于2025年9月22日(星期一)至9月26日(星期五)16:00前登录上证路演中心网站首 页点击"提问预征集"栏目或通过珀莱雅化妆品股份有限公司（以下简称"公司"）投资者关系邮箱 （proyazq@proya.com）进行提问。公司将在说明会上对投资者普遍关注的问题进行回答。 公司于202 ...

公司于 2025 年 8 月 27 日在上海证券交易所网站（www.sse.com.cn）披露公 司《2025 年半年度报告》，为便于广大投资者更全面深入地了解公司 2025 年半 年度的经营成果、财务状况，公司计划于 2025 年 9 月 29 日(星期一)14:00-15:00 举行 2025 年半年度业绩说明会，就投资者关心的问题进行交流。 一、说明会类型 本次投资者说明会以图文展示+网络文字互动问答方式召开，公司将针对 2025 年半年度的经营成果及财务指标的具体情况与投资者进行互动交流和沟通， 在信息披露允许的范围内就投资者普遍关注的问题进行回答。 珀莱雅化妆品股份有限公司 关于召开 2025 年半年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 问题征集方式：投资者可于 2025 年 9 月 22 日(星期一)至 9 月 26 日(星期 五)16:00 前登录上证路演中心网站首页点击"提问预征集"栏目或通过珀莱雅 化妆品股份有限公司（以下简称"公司"）投资者关系邮箱（proyaz ...

Core Viewpoint - The recent advertisement by Nanfu Battery has sparked controversy due to its perceived insensitivity towards the realities of workers, highlighting a disconnect between marketing strategies and public sentiment [3][4]. Group 1: Advertisement Controversy - A Nanfu advertisement displayed on high-speed train seat tables has drawn criticism for its overly enthusiastic portrayal of work-related travel, which contrasts sharply with the sentiments of many workers [3]. - The ad's language has been described as sycophantic and has been labeled as "borderline offensive" by some netizens, indicating a failure to resonate with the target audience [3][4]. - Despite generating significant public attention, the effectiveness of such "edgy" marketing tactics is questioned, as they may not lead to long-term brand loyalty or positive reputation [3][4]. Group 2: Marketing Strategy and Public Perception - The controversy reflects a broader societal sensitivity towards workplace culture and advertising expressions, suggesting that companies need to be more attuned to public sentiment [4]. - Nanfu's marketing department is currently evaluating the appropriateness of the advertisement, indicating a recognition of the need for better alignment between marketing messages and audience perceptions [4]. - The placement of the ad in a public transport setting raises questions about the appropriateness of such content in shared spaces, highlighting the need for stricter oversight in advertising practices [4].

Global Market Overview - The Hang Seng Index closed at 26,439, up 0.19% for the day and up 31.80% year-to-date [2] - The Southbound capital recorded a net inflow of HKD 3.189 billion [2] - The Chinese stock market showed mixed results, with sectors like consumer discretionary and industrial technology rising, while materials, healthcare, and real estate fell [2] Economic Indicators - China's Ministry of Commerce plans to promote orderly opening in the internet and cultural sectors [2] - Japan's government is expected to increase fiscal expansion, with potential tax cuts for households and inflation subsidies [2] - The U.S. retail sales increased by 0.6% month-on-month in August, marking the third consecutive month of exceeding expectations [3] Sector Performance - The automotive sector shows strong potential with companies like Geely Automobile and XPeng Motors rated as "Buy" with target prices indicating significant upside [4] - The equipment manufacturing sector, including companies like SANY International and Zoomlion, is also rated as "Buy" with positive growth forecasts [4] - The consumer discretionary sector, particularly Luckin Coffee and Green Tea Group, is highlighted for its growth potential, with target prices suggesting substantial upside [4] Investment Recommendations - Geely Automobile (175 HK) is rated "Buy" with a target price of HKD 25.00, indicating a 31% upside [4] - SANY International (631 HK) is rated "Buy" with a target price of HKD 8.90, suggesting a 29% upside [4] - Luckin Coffee (LKNCY US) is rated "Buy" with a target price of USD 44.95, indicating a 14% upside [4]

Group 1: Stock Recommendations - Recommended stocks include Geely Automobile (175 HK), Li Auto (9863 HK), Zoomlion (1157 HK), Sany International (631 HK), and Luckin Coffee (LKNCY US) with "Buy" ratings[5] - Target price for Geely Automobile is set at 25.00, indicating a potential upside of 36%[5] - Luckin Coffee has a target price of 44.95, representing a potential upside of 16%[5] Group 2: Financial Metrics - Geely Automobile has a market capitalization of $24.0 billion and a P/E ratio of 10.50 for FY24A[5] - Li Auto's market cap is $11.0 billion with a projected P/E ratio of 9.90 for FY25E[5] - The average dividend yield for the recommended stocks ranges from 0.0% (Luckin Coffee) to 5.2% (Green Tea Group)[5] Group 3: Performance Overview - The basket of 25 stocks listed in the previous report achieved an average return of 2.5%, compared to the MSCI China Index return of 6.8%[10] - Out of the 25 stocks, 10 outperformed the benchmark index[10] Group 4: Recent Changes - New addition to the recommended stocks is Guoquan Food (2517 HK) with a "Buy" rating[7] - Jiangnan Buyi (3306 HK) has been removed from the recommended list[7]

Core Viewpoint - The Chinese beauty industry is experiencing a significant transformation driven by strategic investments in cutting-edge technology and content-driven brands, indicating a shift towards a more integrated and innovative market structure [4][25][28]. Investment Trends - In the first nine months of 2025, Chinese beauty companies completed 13 investments/acquisitions, with disclosed amounts exceeding 5.5 billion RMB, accounting for nearly 60% of the industry's capital flow [4][6]. - Major funding is concentrated in a few leading projects, indicating a selective investment phase, with the top three projects totaling nearly 5.2 billion RMB [6]. - The focus on technology and raw materials is evident, with regenerative medicine and RNA technology becoming key investment areas [7][24]. Strategic Investments - Huaxi Biological's investment in Saintno Pharmaceutical is a prime example of the focus on small nucleic acid drugs, which have significant potential despite the company currently lacking product sales [7][12]. - Proya's investment in Huazhi Xiao aims to build a business ecosystem, leveraging the brand's influence among young consumers and its potential for overseas expansion [10][13]. International Comparison - International giants like L'Oréal and Unilever are also active in the beauty investment space, with L'Oréal completing eight investments and Unilever seven in the first nine months of the year [14][19]. - The investment logic of international players tends to favor acquiring mature brands, while Chinese companies emphasize strategic collaboration and investment in technology [23][24]. Future Outlook - The current investment trends suggest a restructuring of the Chinese beauty industry, moving towards a model supported by technology, content, and global asset integration [25][30]. - The capital influx is raising industry standards, potentially eliminating smaller players lacking differentiation while providing growth opportunities for niche and innovative brands [24][25]. - The evolving landscape indicates that the future of the global beauty industry may be significantly influenced by the capital dynamics within China, potentially leading to the emergence of new world-class beauty giants from the Chinese capital ecosystem [30].

Market Overview - On September 16, the cosmetics sector rose by 0.03% compared to the previous trading day, with Shuiyang Co., Ltd. leading the gains [1] - The Shanghai Composite Index closed at 3861.87, up 0.04%, while the Shenzhen Component Index closed at 13063.97, up 0.45% [1] Individual Stock Performance - Shuiyang Co., Ltd. (300740) closed at 22.48, with a gain of 1.63% and a trading volume of 208,500 shares, amounting to a transaction value of 469 million yuan [1] - Qingdao Kingway (002094) closed at 8.47, up 1.44%, with a trading volume of 326,600 shares and a transaction value of 277 million yuan [1] - Other notable performers include: - Kezhou Co., Ltd. (300856) at 14.23, up 0.57% [1] - Beitaini (300957) at 49.13, up 0.41% [1] - Furuida (600223) at 7.91, up 0.38% [1] Fund Flow Analysis - The cosmetics sector experienced a net outflow of 43.2 million yuan from institutional investors, while retail investors saw a net outflow of 23.0 million yuan [2] - Conversely, speculative funds recorded a net inflow of 66.2 million yuan [2] Detailed Fund Flow for Key Stocks - Shuiyang Co., Ltd. (300740) had a net inflow of 41.1 million yuan from institutional investors, while retail investors faced a net outflow of 71.8 million yuan [3] - Qingdao Kingway (002094) saw a net inflow of 15.3 million yuan from institutional investors, but a net outflow of 7.2 million yuan from retail investors [3] - Other stocks with significant fund flow include: - Beitaini (300957) with a net inflow of 5.7 million yuan from institutional investors and a net outflow of 13.2 million yuan from retail investors [3] - Furuida (600223) faced a net outflow of 10.2 million yuan from institutional investors but a net inflow of 8.9 million yuan from retail investors [3]

Market Overview - On September 15, the cosmetics sector declined by 0.18%, with Huaye Fragrance leading the drop [1] - The Shanghai Composite Index closed at 3860.5, down 0.26%, while the Shenzhen Component Index closed at 13005.77, up 0.63% [1] Individual Stock Performance - Notable gainers included: - Jinsong New Material (300849) with a closing price of 14.48, up 3.72% and a trading volume of 121,800 shares, totaling 179 million yuan [1] - Lafang Home (603630) closed at 28.58, up 2.11% with a trading volume of 71,300 shares, totaling 200 million yuan [1] - Notable decliners included: - Huaye Fragrance (300886) closed at 29.66, down 1.79% with a trading volume of 18,400 shares, totaling 55.05 million yuan [2] - Marubi Biological (603983) closed at 39.95, down 1.36% with a trading volume of 13,900 shares, totaling 55.49 million yuan [2] Capital Flow Analysis - The cosmetics sector experienced a net outflow of 83.38 million yuan from institutional investors, while retail investors saw a net inflow of 76.42 million yuan [2] - The overall capital flow for individual stocks showed: - Jinsong New Material had a net inflow of 18.50 million yuan from institutional investors, accounting for 10.31% of its total [3] - Huaye Fragrance had a net outflow of 4.23 million yuan from institutional investors, accounting for 6.58% of its total [3]

Investment Rating - The investment rating for the company is "Buy" and is maintained [6]. Core Views - The company reported a revenue of 5.36 billion yuan for H1 2025, representing a year-on-year growth of 7.2%, while the net profit attributable to shareholders was 800 million yuan, up 13.8% year-on-year. In Q2 alone, revenue was 3 billion yuan, with a year-on-year increase of 6.5%, and net profit of 410 million yuan, growing 2.4% year-on-year [2][4]. - The company plans to issue H shares and list on the Hong Kong Stock Exchange to accelerate its international strategy and overseas business development, as well as enhance its overseas financing capabilities [2][4]. Financial Performance - In H1 2025, online direct sales, online distribution, and offline sales generated revenues of 3.91 billion, 1.2 billion, and 250 million yuan respectively, with year-on-year changes of 4.9%, 25.9%, and -21.5% [9]. - The main brand and sub-brands showed varied performance, with the main brand's revenue slightly declining by 0.1%, while sub-brands like OR and 原色波塔 saw significant growth of 103% and 80% respectively [9]. - The gross profit margin improved by 3.6 percentage points in H1 2025, attributed to cost reduction and efficiency improvements [9]. - The overall net profit margin increased by 0.9 percentage points to 14.9%, although Q2 saw a slight decline of 0.5 percentage points to 13.6% due to increased sales expenses during promotional periods [9]. Future Outlook - The company is expected to benefit from the ongoing expansion of its main brand and the continued strong performance of its sub-brands, which could contribute to incremental growth [9]. - EPS forecasts for 2025, 2026, and 2027 are projected to be 4.28, 5.05, and 5.77 yuan per share respectively [9].

Investment Rating - The report initiates coverage with a "Buy" rating for Shuiyang Co., Ltd. [3][13] Core Insights - The cosmetics and medical beauty sector underperformed the market, with the Shenwan Beauty Care Index increasing by 0.2% from September 5 to September 12, 2025, lagging behind the Shenwan A Index by 2.7 percentage points [3][4] - Domestic cosmetics brands showed strong growth in August, with key brands under Shumei Co. achieving a 70% growth rate on Douyin and Taobao platforms, indicating a robust performance despite high base effects [3][9] - The report highlights the upcoming Double 11 shopping festival, suggesting that brands should prepare for promotional strategies [3][9] Summary by Sections Industry Performance - The cosmetics and medical beauty sector's performance was weaker than the market, with declines in the Shenwan Cosmetics Index by 0.5% and the Shenwan Personal Care Index by 0.8% during the specified period [3][4] Key Company Review - Shuiyang Co., Ltd. is positioned as a leading technology-driven beauty company in China, with stable revenue between 4 to 5 billion yuan from 2021 to 2024 and an expected gross margin of 63.01% in 2024, up by 10.94 percentage points from 2021 [3][10] - The company has a dual business model of proprietary brands and CP agency brands, with a strong focus on high-end and global market transformation [3][10][12] E-commerce Data - In August, key domestic brands on Douyin and Taobao platforms showed significant growth, with Shumei Co. brands achieving a 70% increase, and other brands like Maogeping and Runben also reporting substantial growth rates [3][14] Market Trends - The report notes that the overall retail sales of cosmetics in July 2025 grew by 4.5%, indicating a recovery in consumer spending [3][17] - The domestic skincare market is projected to reach 271.2 billion yuan in 2024, despite a slight decline of 3.7% year-on-year, with domestic brands gaining market share [3][26] Company Announcements - Shumei Co. has appointed Dr. Karl Lintner, a pioneer in peptide beauty, as the chief scientific advisor, aiming to enhance its global competitiveness in research and development [3][21]